Kazia Therapeutics Ltd ADR ( KZIA) - Key Metrics
KZIA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | ? | ? | ? | ? |
| 2024Q2 | $0 | -$0.37 | -$0.26 | -$0.26 |
| 2023Q4 | $0 | -$0.32 | -$0.29 | -$0.29 |
| 2023Q2 | ? | -$0.93 | -$0.60 | -$0.60 |
| 2023Q1 | ? | -$0.05 | -$0.03 | -$0.03 |
KZIA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | ? |
| 2024Q2 | ? | -4.49 |
| 2023Q4 | ? | -13.65 |
| 2023Q2 | ? | -2.42 |
| 2023Q1 | ? | -92.11 |
KZIA
Price: $13.52
52 week price:
Earnings Per Share: -13.02 USD
P/E Ratio: -0.65
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Volume: 38900
Market Capitalization: 20.0 million